The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Then the men sat down at desktop computers, opened their Microsoft Excel spreadsheets and began to type. Excel, a program that does complex math on a human’s behalf, is often associated ...

A recent The New York Times piece peeled back the cover on the e-sport you didn't know you were missing: the Microsoft Excel World Championship. Last month in Las Vegas, 12 men ran through a pro ...

At the Microsoft Excel World Championship in Las Vegas, there was stardust in the air as 12 finance guys vied to be crowned the world’s best spreadsheeter. transcript The event’s organizer ...

Microsoft has introduced lots of new features to its Excel app recently, aimed at enhancing productivity, simplifying data analysis, and improving usability across desktop, web, Mac, and iPad ...

Every marketing campaign template in this guide is 100% free to use. Some work with standard tools you might already have, like Excel, Google Sheets, or Google Docs, while others require you to ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program that the HHS claims violates anti-kickback statutes. In a court filing on ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the ...